Cargando…

Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing

Current antiviral therapy fails to cure chronic hepatitis B virus (HBV) infection because of persistent covalently closed circular DNA (cccDNA). CRISPR/Cas9-mediated specific cleavage of cccDNA is a potentially curative strategy for chronic hepatitis B (CHB). However, the CRISPR/Cas system inevitabl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yu-Chan, Chen, Yu-Hsiang, Kao, Jia-Horng, Ching, Chi, Liu, I-Jung, Wang, Chih-Chiang, Tsai, Cheng-Hsueh, Wu, Fang-Yi, Liu, Chun-Jen, Chen, Pei-Jer, Chen, Ding-Shinn, Yang, Hung-Chih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150432/ https://www.ncbi.nlm.nih.gov/pubmed/32278307 http://dx.doi.org/10.1016/j.omtn.2020.03.005

Ejemplares similares

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo
por: Lin, Su-Ru, et al.
Publicado: (2014)

Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas
por: Yang, Yu-Chan, et al.
Publicado: (2021)

HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice
por: Horng, Jau-Hau, et al.
Publicado: (2020)

CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage
por: Sun, Jichao, et al.
Publicado: (2019)

The CRISPR‐Cas13a Gene‐Editing System Induces Collateral Cleavage of RNA in Glioma Cells
por: Wang, Qixue, et al.
Publicado: (2019)

Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2017)

Application of CRISPR/Cas9 Technology to HBV
por: Lin, Guigao, et al.
Publicado: (2015)

Inactivation of Target RNA Cleavage of a III-B CRISPR-Cas System Induces Robust Autoimmunity in Saccharolobus islandicus
por: Zhang, Yan, et al.
Publicado: (2022)

Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9
por: Li, Hao, et al.
Publicado: (2018)

In vivo PCSK9 gene editing using an all-in-one self-cleavage AAV-CRISPR system
por: Li, Qian, et al.
Publicado: (2021)

Sequence features associated with the cleavage efficiency of CRISPR/Cas9 system
por: Liu, Xiaoxi, et al.
Publicado: (2016)

CRISPR/Cas9-based gene activation and base editing in Populus
por: Yao, Tao, et al.
Publicado: (2023)

Definition of CRISPR Cas12a Trans-Cleavage Units to Facilitate CRISPR Diagnostics
por: Lv, Hailong, et al.
Publicado: (2021)

Efficient cleavage resolves PAM preferences of CRISPR-Cas in human cells
por: Tang, Lianchao, et al.
Publicado: (2019)

Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage
por: Riesenberg, Stephan, et al.
Publicado: (2022)

CRISPR/Cas9 delivery by NIR-responsive biomimetic nanoparticles for targeted HBV therapy
por: Wang, Dan, et al.
Publicado: (2022)

Expanding the CRISPR/Cas genome-editing scope in Xenopus tropicalis
por: Shi, Zhaoying, et al.
Publicado: (2022)

Spatiotemporal control of CRISPR/Cas9 gene editing
por: Zhuo, Chenya, et al.
Publicado: (2021)

HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
por: Liu, Nan, et al.
Publicado: (2022)

HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
por: Liu, Nan, et al.
Publicado: (2022)

Two HEPN domains dictate CRISPR RNA maturation and target cleavage in Cas13d
por: Zhang, Bo, et al.
Publicado: (2019)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV
por: Ding, Ronghua, et al.
Publicado: (2021)

Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection
por: Su, Tung-Hung, et al.
Publicado: (2013)

Mechanistic insights into the R-loop formation and cleavage in CRISPR-Cas12i1
por: Zhang, Bo, et al.
Publicado: (2021)

Protoplasts: From Isolation to CRISPR/Cas Genome Editing Application
por: Yue, Jin-Jun, et al.
Publicado: (2021)

Collateral Effects: The CRISPR‐Cas13a Gene‐Editing System Induces Collateral Cleavage of RNA in Glioma Cells (Adv. Sci. 20/2019)
por: Wang, Qixue, et al.
Publicado: (2019)

Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs
por: Rose, John C., et al.
Publicado: (2020)

Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
por: Liu, Chen-Hua, et al.
Publicado: (2018)

Programmable RNA recognition and cleavage by CRISPR/Cas9
por: O’Connell, Mitchell R., et al.
Publicado: (2014)

Methods for in vitro CRISPR/CasRx-Mediated RNA Editing
por: Chuang, Yu-Fan, et al.
Publicado: (2021)

Structural insights into DNA cleavage activation of CRISPR-Cas9 system
por: Huai, Cong, et al.
Publicado: (2017)

A cleavage-based surrogate reporter for the evaluation of CRISPR–Cas9 cleavage efficiency
por: Jung, Soo Bin, et al.
Publicado: (2021)

Improved genome editing by an engineered CRISPR-Cas12a
por: Ma, Enbo, et al.
Publicado: (2022)

Application progress of CRISPR/Cas9 genome-editing technology in edible fungi
por: Zhang, Yan, et al.
Publicado: (2023)

A CRISPR/Cas9 toolkit for multiplex genome editing in plants
por: Xing, Hui-Li, et al.
Publicado: (2014)

Structural insights into target DNA recognition and cleavage by the CRISPR-Cas12c1 system
por: Zhang, Bo, et al.
Publicado: (2022)

A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9
por: Dagdas, Yavuz S., et al.
Publicado: (2017)

Outbred genome sequencing and CRISPR/Cas9 gene editing in butterflies
por: Li, Xueyan, et al.
Publicado: (2015)

CRISPR-Cas9-Based Genome Editing and Cytidine Base Editing in Acinetobacter baumannii
por: Wang, Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kc2dcssfno0bav3nrcoj3oqujd